FAM167A is a key molecule to induce BCR-ABL-independent TKI resistance in CML via noncanonical NF-κB signaling activation

Taewoo Yang(Gwangju Institute of Science and Technology), Sung‐Gyoo Park(Gwangju Institute of Science and Technology)
Journal of Experimental & Clinical Cancer Research
March 3, 2022
Cited by 23


Related Papers